Where Lyra Therapeutics Stands With Analysts
Where Lyra Therapeutics Stands With Analysts
Lyra Therapeutics 在分析師中的立場
Analysts' ratings for Lyra Therapeutics (NASDAQ:LYRA) over the last quarter vary from bullish to bearish, as provided by 5 analysts.
5位分析師提供的分析師對Lyra Therapeutics（納斯達克股票代碼：LYRA）在上個季度的評級從看漲到看跌不等。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表簡要介紹了他們最近的評級，展示了過去30天情緒的演變，並將其與前幾個月進行了比較。
Analysts have recently evaluated Lyra Therapeutics and provided 12-month price targets. The average target is $7.5, accompanied by a high estimate of $12.00 and a low estimate of $0.50. A decline of 31.82% from the prior average price target is evident in the current average.
分析師最近對Lyra Therapeutics進行了評估，並提供了12個月的目標股價。平均目標爲7.5美元，最高估計值爲12.00美元，低估值爲0.50美元。目前的平均價格比先前的平均目標股價下降了31.82％。
Decoding Analyst Ratings: A Detailed Look
解碼分析師評級：詳細介紹
A comprehensive examination of how financial experts...
對金融專家如何...
登入免費觀看全文
登入/註冊